Godrej Agrovet crossed ₹10,000 crore revenue in FY26 at ₹10,233 crore. Q4 revenue ₹2,333 crore, FY26 PBT ₹569 crore. Oil palm FFB 6,37,000 tons — demographic dividend peak productivity tailwind. FY27: early double-digit revenue, mid-teens PBT growth. Capex ₹350-400 crore. Good sentiment, high confidence (milestone achieved, oil palm productivity cycle, agri diversification, FY27 guidance visible).
Headline Numbers
| Metric | FY26 / Q4 FY26 | Notes |
|---|---|---|
| FY26 Revenue | ₹10,233 crore | ₹10,000 cr milestone |
| Q4 Revenue | ₹2,333 crore | — |
| FY26 PBT (ex-exceptional) | ₹569 crore | — |
| Q4 PBT (ex-exceptional) | ₹87 crore | — |
| FFB Processed FY26 | 6,37,000 tons | — |
| Pet Food Profit (Q4) | ₹9.5 crore | — |
| FY27 Revenue Growth | Early double-digit | Guidance |
| FY27 PBT Growth | Mid-teens | Guidance |
| FY27 Capex | ₹350-400 crore | — |
What Drove the Results
- ₹10,000 crore revenue milestone — diversified agri platform at scale: Crossing ₹10,000 crore validates Godrej Agrovet's diversified agri-business model: animal feed + oil palm + crop protection + dairy each contributing. At this scale, procurement advantages, brand power, and distribution leverage compound. The milestone also signals to institutional investors that GAVL is a large-cap agri story — not a niche specialty play.
- Oil palm demographic dividend — peak productivity ahead: Godrej Agrovet's oil palm plantations are entering peak productivity years. Oil palm trees yield the most FFB between years 7-15 of their lifespan — with the same land and farmer base, FFB output increases structurally without additional investment. The 6,37,000 tons FY26 is expected to grow to 7,00,000-7,50,000 tons by FY28 organically. At ₹5,000-6,000 per ton contribution, each 50,000 ton increase = ₹25-30 crore additional PBT.
- Animal feed + aqua feed — structural demand growth: India's aquaculture (shrimp, fish farming) is growing rapidly as exports recover and domestic consumption grows. Aqua feed is the highest-margin animal feed segment. Godrej Agrovet's Venkys and GAVL animal feed brands cover poultry, cattle, and aqua — diversified demand across the protein value chain. Animal feed is the revenue workhorse — large, consistent, and growing.
- Crop protection portfolio diversification — reducing single-product dependency: Astec LifeSciences (GAVL subsidiary) provides crop protection APIs. The agrochemical cycle (global crop protection demand went through a destocking downcycle in FY24-25) is recovering. Astec is also diversifying its product portfolio to reduce dependency on any single crop protection ingredient. FY27 recovery in agrochemical demand will boost Astec's contribution to group PBT.
- Mid-teens PBT growth guidance — operating leverage on ₹10,000 crore base: At ₹10,233 crore revenue, mid-teens PBT growth implies ₹570 → ₹650-660 crore PBT in FY27 — approximately ₹80-90 crore incremental PBT. This comes from: oil palm demographic dividend (₹25-30 crore), animal feed volume leverage (₹20-25 crore), Astec recovery (₹15-20 crore), and dairy improvement (₹10-15 crore).
What Management Said
Management was confident on diversified growth while acknowledging near-term Iran risk. On milestone: "₹10,000 crore revenue — a significant milestone for GAVL. Our diversified model is proving its resilience." On oil palm: "The oil palm demographic dividend is real — our trees are entering peak productivity. FFB yield per hectare is improving. This is margin-accretive without incremental investment." On FY27: "Early double-digit revenue, mid-teens PBT — we have clear growth drivers across all segments." On Iran: "We flagged Iran war risk — it could impact Q1 FY27 crop protection export demand and crude prices. Our base case is manageable impact." On capex: "₹350-400 crore FY27 — oil palm area expansion, animal feed capacity, dairy."
Key Tailwinds and Risks
Tailwinds:
- Oil palm demographic dividend — installed tree base entering peak productivity years
- India aquaculture growth — shrimp exports and domestic fish consumption driving aqua feed
- NMEO-OP — government subsidy programme for oil palm farming increasing farmer participation
- Agrochemical cycle recovery — Astec LifeSciences volume normalising after destocking cycle
- Diversification — 5 business segments reduce single-segment risk
Risks:
- Iran conflict — potential impact on agri commodity export demand and input costs (crude)
- Monsoon dependency — below-normal monsoon impacts crop protection demand and farm incomes
- Agrochemical price pressure — generic competition in crop protection compressing margins
- Dairy competition — regional dairy cooperatives (Amul, NDDB affiliates) competing aggressively
- Palm oil price volatility — crude palm oil prices are globally traded; INR/USD and global prices affect margins
StockMirror AI Signal Summary
| Signal | Reading |
|---|---|
| Overall Sentiment | Good |
| Management Confidence | High |
| Prepared Remarks | Good — ₹10,000 cr milestone, oil palm dividend, FY27 guidance |
| Q&A Sentiment | Good — candid on Iran risk, confident on underlying growth drivers |
| Revenue Growth | Strong — milestone FY26; double-digit FY27 guidance |
| Margin Direction | Improving — mid-teens PBT growth on operating leverage + oil palm dividend |
| Earnings Quality | Good — diversified segments; no single-point revenue risk |
Track Godrej Agrovet's full AI earnings breakdown — oil palm FFB trajectory, animal feed growth, and PBT path — at Godrej Agrovet's earnings page.
Key Takeaways
- FY26 revenue ₹10,233 crore (₹10,000 crore milestone); Q4 ₹2,333 crore; FY26 PBT ₹569 crore
- Oil palm FFB 6,37,000 tons — demographic dividend (peak productivity years) driving margin improvement
- FY27: early double-digit revenue growth, mid-teens PBT growth; capex ₹350-400 crore
- Iran conflict flagged as near-term risk for Q1 FY27 agri exports
- Diversified platform: animal feed, oil palm, crop protection, dairy, Astec LifeSciences
Frequently Asked Questions
What is Godrej Agrovet's FY26 revenue milestone? Godrej Agrovet crossed the ₹10,000 crore revenue milestone in FY26 with consolidated revenue of ₹10,233 crore. Q4 FY26 revenue: ₹2,333 crore. FY26 PBT (excluding exceptional items): ₹569 crore. FFB processed: 6,37,000 tons. FY27 guidance: early double-digit revenue growth, mid-teens PBT growth. Capex: ₹350-400 crore.
What is the oil palm demographic dividend? Godrej Agrovet's oil palm trees are entering their peak productivity years (years 7-15). The same tree base produces more FFB (Fresh Fruit Bunches) per hectare as trees mature — without additional plantation investment. This creates margin-accretive revenue growth from the existing asset base. FFB yield improvement from 6,37,000 tons toward 7,00,000-7,50,000 tons adds ₹25-30 crore annually to PBT at no incremental cost.
What are Godrej Agrovet's FY27 growth drivers? FY27 double-digit revenue and mid-teens PBT growth will come from: (1) oil palm demographic dividend — higher FFB per hectare, (2) aqua feed scaling — India shrimp export recovery, (3) Astec LifeSciences — agrochemical cycle recovery and portfolio diversification, (4) dairy expansion in South India, and (5) crop protection portfolio broadening beyond single-ingredient dependency.
Related: UPL Q4 FY26 · Rallis India Q4 FY26
Disclaimer: This article is for informational purposes only and does not constitute investment advice. StockMirror's AI analysis is based on publicly available earnings transcripts and BSE/NSE filings. Please consult a SEBI-registered financial advisor before making investment decisions.